Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Covington
Chubb
US Department of Justice
US Army
Daiichi Sankyo
Fuji
Medtronic
Dow

Generated: February 18, 2018

DrugPatentWatch Database Preview

Bayer Company Profile

« Back to Dashboard

What is the competitive landscape for BAYER, and when can generic versions of BAYER drugs launch?

BAYER has one hundred and twenty-seven approved drugs.

There are forty-nine US patents protecting BAYER drugs and there have been two Paragraph IV challenges on BAYER drugs in the past three years.

There are one thousand four hundred and fifty-nine patent family members on BAYER drugs in seventy-five countries and one hundred and eighty-one supplementary protection certificates in sixteen countries.

Summary for Bayer
International Patents:1459
US Patents:49
Tradenames:110
Ingredients:75
NDAs:127

Drugs and US Patents for Bayer

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare ADEMPAS riociguat TABLET;ORAL 204819-005 Oct 8, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare CIPRO ciprofloxacin INJECTABLE;INJECTION 019847-003 Dec 26, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare LEVITRA vardenafil hydrochloride TABLET;ORAL 021400-003 Aug 19, 2003 RX Yes No 8,841,446 ➤ Try a Free Trial Y ➤ Try a Free Trial
Bayer Pharms CORT-DOME hydrocortisone LOTION;TOPICAL 009895-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare AVELOX moxifloxacin hydrochloride TABLET;ORAL 021085-001 Dec 10, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare OSMOVIST 190 iotrolan INJECTABLE;INTRATHECAL 019580-001 Dec 7, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare AVELOX moxifloxacin hydrochloride TABLET;ORAL 021085-001 Dec 10, 1999 AB RX Yes Yes 6,610,327 ➤ Try a Free Trial Y ➤ Try a Free Trial
Bayer Healthcare Llc GYNE-LOTRIMIN 3 clotrimazole TABLET;VAGINAL 020525-001 Jul 29, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Bayer Hlthcare NEXAVAR sorafenib tosylate TABLET;ORAL 021923-001 Dec 20, 2005 RX Yes Yes 9,737,488 ➤ Try a Free Trial Y ➤ Try a Free Trial
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Bayer

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare CIPRO ciprofloxacin FOR SUSPENSION;ORAL 020780-001 Sep 26, 1997 6,136,347*PED ➤ Try a Free Trial
Bayer Hlthcare CIPRO XR ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021473-001 Dec 13, 2002 4,670,444*PED ➤ Try a Free Trial
Bayer Hlthcare GADAVIST gadobutrol SOLUTION;INTRAVENOUS 201277-005 Mar 14, 2011 5,980,864 ➤ Try a Free Trial
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-001 Apr 8, 1996 4,670,444*PED ➤ Try a Free Trial
Bayer Hlthcare YAZ drospirenone; ethinyl estradiol TABLET;ORAL 021676-001 Mar 16, 2006 6,933,395 ➤ Try a Free Trial
Bayer Hlthcare ULTRAVIST (PHARMACY BULK) iopromide INJECTABLE;INJECTION 021425-002 Sep 20, 2002 4,364,921 ➤ Try a Free Trial
Bayer Pharms ADALAT nifedipine CAPSULE;ORAL 019478-001 Nov 27, 1985 3,784,684 ➤ Try a Free Trial
Bayer Hlthcare FINACEA azelaic acid GEL;TOPICAL 021470-001 Dec 24, 2002 4,713,394 ➤ Try a Free Trial
Bayer Hlthcare MYCELEX clotrimazole SOLUTION;TOPICAL 018181-001 Approved Prior to Jan 1, 1982 3,839,573 ➤ Try a Free Trial
Bayer Hlthcare AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER moxifloxacin hydrochloride SOLUTION;IV (INFUSION) 021277-001 Nov 30, 2001 4,990,517 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for BAYER drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Foam 15% ➤ Subscribe 9/14/2017
➤ Subscribe Tablets 40 mg ➤ Subscribe 9/27/2016
➤ Subscribe Tablets 0.25 mg/0.5 mg ➤ Subscribe 1/8/2015
➤ Subscribe Tablets 200 mg ➤ Subscribe 2/28/2014
➤ Subscribe Injection 1.6 mg/mL ➤ Subscribe 2/7/2014
➤ Subscribe Tablets 3 mg/0.02 mg/0.451 mg and 0.451 mg ➤ Subscribe 11/13/2012
➤ Subscribe Tablets 3 mg/0.03 mg/0.451 mg and 0.451 mg ➤ Subscribe 9/28/2012
➤ Subscribe Gel 15% ➤ Subscribe 7/27/2012
➤ Subscribe Orally Disintegrating Tablets 10 mg ➤ Subscribe 12/22/2011
➤ Subscribe Tablets 3 mg/0.02 mg/0.451 mg and 0.451 mg ➤ Subscribe 11/21/2011
➤ Subscribe Gel 0.05% ➤ Subscribe 12/1/2010
➤ Subscribe Tablets 3 mg; 2 mg/2 mg; 2 mg/3 mg; 1 mg ➤ Subscribe 10/22/2010
➤ Subscribe Capsules 20 mg/1100 mg ➤ Subscribe 4/20/2010
➤ Subscribe Oral Suspension 250 mg/5 mL and 500 mg/ 5 mL ➤ Subscribe 10/16/2009
➤ Subscribe Tablets 2.5 mg ➤ Subscribe 9/4/2009
➤ Subscribe Tablets 5 mg ad 10 mg ➤ Subscribe 7/10/2009
➤ Subscribe Tablets 20 mg ➤ Subscribe 3/5/2009
➤ Subscribe Tablets 0.5 mg/1 mg ➤ Subscribe 12/26/2007
➤ Subscribe Tablets 3 mg/0.02 mg ➤ Subscribe 9/29/2006
➤ Subscribe Transdermal System 0.05 mg/day and 0.1 mg/day ➤ Subscribe 9/12/2005
➤ Subscribe Tablets 25 mg, 50 mg and 100 mg ➤ Subscribe 3/22/2005
➤ Subscribe Tablets 3 mg/0.03 mg ➤ Subscribe 1/7/2005
Premature patent expirations for BAYER

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Try a Free Trial ➤ Try a Free Trial

Non-Orange Book US Patents for Bayer

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,795,635 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses ➤ Try a Free Trial
9,101,662 Compositions with modulating agents ➤ Try a Free Trial
5,798,092 Derivatized DTPA complexes pharmaceutical agents containing these compounds, their use, and processes for their production ➤ Try a Free Trial
7,528,255 Hydroxy, .omega.-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors ➤ Try a Free Trial
9,452,082 Inserter ➤ Try a Free Trial
6,517,847 Topical gel delivery system ➤ Try a Free Trial
7,704,999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors ➤ Try a Free Trial
8,629,128 Vitamin formulation ➤ Try a Free Trial
7,569,557 Compositions of estrogen-cyclodextrin complexes ➤ Try a Free Trial
7,820,145 Oleaginous pharmaceutical and cosmetic foam ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Bayer Drugs

Supplementary Protection Certificates for Bayer Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90067-4 Sweden ➤ Try a Free Trial PRODUCT NAME: COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE; REG. NO/DATE: EU/1/14/974 20140918
C/GB04/036 United Kingdom ➤ Try a Free Trial PRODUCT NAME: INSULIN DETEMIR, NEB29- TETRADECANOYL- DES(B30) HUMAN INSULIN; NATL REGISTRATION NO/DATE: EU/1/04/278/001-009 20040601; FIRST REGISTRATION: CH 56370, 56311, 56372 20031110
2013000061 Germany ➤ Try a Free Trial PRODUCT NAME: INSULIN DEGLUDEC IN ALLEN DURCH DAS BASISPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/12/807/001 EU/1/12/807/004-005 EU/1/12/807/007-009 EU/1/12/807/012-013 EU/1/12/807/015 20130121
156 Luxembourg ➤ Try a Free Trial PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211
2014018 Lithuania ➤ Try a Free Trial PRODUCT NAME: ; REGISTRATION NO/DATE: EU/1/13/907/001 - EU/1/13/907/015 20140327
8 50005-2014 Slovakia ➤ Try a Free Trial PRODUCT NAME: PAKLITAXEL VO FORME NANOCASTIC VIAZANYCH NA ALBUMIN; REGISTRATION NO/DATE: EU/1/07/428/001 - EU/1/07/428/002 20131230
2017000040 Germany ➤ Try a Free Trial PRODUCT NAME: SCHNELL-WIRKENDES INSULIN ASPART; REGISTRATION NO/DATE: EU/1/16/1160 20170109
C0035 France ➤ Try a Free Trial PRODUCT NAME: INSULINE DEGLUDEC; REGISTRATION NO/DATE: EU/1/12/807/001 20130121
2014 00027 Denmark ➤ Try a Free Trial PRODUCT NAME: RADIUM-223 OG OPLOESELIGE SALTE DERAF, HERUNDER RADIUM-223 DICHLORID; REG. NO/DATE: EU/1/13/873 20131113
5 Finland ➤ Try a Free Trial
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Merck
McKinsey
Farmers Insurance
Mallinckrodt
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot